Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
10.8M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
1.15M
-
Shares change
-
+1.71K
-
Total reported value, excl. options
-
$3.93M
-
Value change
-
-$18K
-
Put/Call ratio
-
3.09
-
Number of buys
-
8
-
Number of sells
-
-9
-
Price
-
$3.41
Significant Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q3 2023
30 filings reported holding LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share as of Q3 2023.
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.15M shares
of 10.8M outstanding shares and own 10.7% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (367K shares), NewEdge Advisors, LLC (170K shares), GEODE CAPITAL MANAGEMENT, LLC (95K shares), CARLSON CAPITAL L P (95K shares), CM Management, LLC (75K shares), Redmond Asset Management, LLC (46.5K shares), RENAISSANCE TECHNOLOGIES LLC (38.1K shares), Pathway Financial Advisors LLC (32.8K shares), CITADEL ADVISORS LLC (30.6K shares), and HORIZON KINETICS ASSET MANAGEMENT LLC (30K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.